SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 10/25/19 Dow Inc. 10-Q 9/30/19 122:20M Dow Chemical Co/DE |
Document/Exhibit Description Pages Size 1: 10-Q Quarterly Report HTML 2.80M 2: EX-23 Ankura Consulting Group, LLC's Consent HTML 40K 3: EX-31.1 Certification Pursuant to Section 302 of the HTML 41K Sarbanes-Oxley Act of 2002 4: EX-31.2 Certification Pursuant to Section 302 of the HTML 41K Sarbanes-Oxley Act of 2002 5: EX-32.1 Certification Pursuant to Section 906 of the HTML 36K Sarbanes-Oxley Act of 2002 6: EX-32.2 Certification Pursuant to Section 906 of the HTML 36K Sarbanes-Oxley Act of 2002 105: R1 Cover Page HTML 95K 67: R2 Dow Consolidated Statements of Income Statement HTML 136K 24: R3 Dow Consolidated Statements of Comprehensive HTML 68K Income Statement 87: R4 Dow Consolidated Balance Sheets Statement HTML 188K 103: R5 Dow Consolidated Balance Sheets Parentheticals HTML 63K 65: R6 Dow Consolidated Statements of Cash Flows HTML 176K Statement 22: R7 Dow Consolidated Statements of Equity Statement HTML 111K 90: R8 Consolidated Statements of Income HTML 110K 101: R9 Consolidated Statements of Comprehensive Income HTML 72K 38: R10 Consolidated Balance Sheets HTML 205K 50: R11 Consolidated Balance Sheets (Parentheticals) HTML 67K 119: R12 TDCC Consolidated Statements of Cash Flows HTML 194K Statement 77: R13 Consolidated Statements of Equity HTML 104K 37: R14 Consolidated Statements of Equity (Parenthetical) HTML 38K 49: R15 Consolidated Financial Statements HTML 54K 118: R16 Recent Accounting Guidance HTML 42K 76: R17 SEPARATION FROM DOWDUPONT Separation from HTML 116K DowDuPont (Notes) 36: R18 Revenue (Notes) HTML 112K 51: R19 Restructuring and Asset Related Charges - Net HTML 164K 99: R20 Supplementary Information HTML 43K 86: R21 Earnings Per Share (Notes) HTML 102K 13: R22 Inventories HTML 47K 54: R23 Nonconsolidated Affiliates HTML 48K 98: R24 Goodwill and Other Intangible Assets HTML 100K 85: R25 Transfers of Financial Assets HTML 42K 12: R26 Notes Payable, Long-Term Debt and Available Credit HTML 133K Facilities 53: R27 Commitments and Contingent Liabilities HTML 86K 100: R28 Leases (Notes) HTML 116K 84: R29 Stockholders' Equity Stockholders' Equity (Notes) HTML 169K 78: R30 NONCONTROLLING INTERESTS Noncontrolling Interests HTML 66K 121: R31 Pension Plans and Other Postretirement Benefits HTML 87K 47: R32 Stock-Based Compensation HTML 44K 34: R33 Financial Instruments HTML 280K 79: R34 Fair Value Measurements HTML 108K 122: R35 Variable Interest Entities HTML 67K 48: R36 Relatd Party Transactions (Notes) HTML 57K 35: R37 Segments and Geographic Regions (Notes) HTML 232K 80: R38 Consolidated Financial Statements Summary of HTML 50K Significant Accounting Policies (Policies) 120: R39 SEPARATION FROM DOWDUPONT Separation from HTML 106K DowDuPont (Tables) 88: R40 Revenue (Tables) HTML 106K 104: R41 Restructuring and Asset Related Charges - Net HTML 38K (Tables) 64: R42 Earnings Per Share (Tables) HTML 102K 21: R43 Inventories (Tables) HTML 49K 89: R44 Nonconsolidated Affiliates (Tables) HTML 42K 106: R45 Goodwill and Other Intangible Assets (Tables) HTML 102K 66: R46 Transfers of Financial Assets (Tables) HTML 41K 23: R47 Notes Payable, Long-Term Debt and Available Credit HTML 132K Facilities (Tables) 91: R48 Commitments and Contingent Liabilities (Tables) HTML 45K 102: R49 Leases (Tables) HTML 136K 112: R50 Stockholders' Equity Stockholders' Equity (Tables) HTML 169K 71: R51 NONCONTROLLING INTERESTS Noncontrolling Interests HTML 64K (Tables) 33: R52 Pension Plans and Other Postretirement Benefits HTML 84K (Tables) 46: R53 Financial Instruments (Tables) HTML 262K 111: R54 Fair Value Measurements (Tables) HTML 99K 70: R55 Variable Interest Entities (Tables) HTML 69K 32: R56 Related Party Transactions (Tables) HTML 50K 45: R57 Segments and Geographic Regions (Tables) HTML 232K 113: R58 CONSOLIDATED FINANCIAL STATEMENTS Changes to HTML 47K Statement of Equity (Details) 69: R59 RECENT ACCOUNTING GUIDANCE Recent Accounting HTML 39K Guidance (Details) 19: R60 SEPARATION FROM DOWDUPONT Separation from HTML 52K DowDuPont (Details) 60: R61 SEPARATION FROM DOWDUPONT Receipt of ECP (Details) HTML 99K 109: R62 SEPARATION FROM DOWDUPONT Discontinued Operations HTML 84K - Income Statement (Details) 94: R63 SEPARATION FROM DOWDUPONT Discontinued Operations HTML 108K - Balance Sheet (Details) 18: R64 SEPARATION FROM DOWDUPONT Separation, Distribution HTML 58K and Tax Agreements (Details) 59: R65 Revenue (Details) HTML 96K 108: R66 Restructuring and Asset Related Charges - Net HTML 39K Restructuring and Asset Related Charges - Net (Other) (Details) 93: R67 Restructuring and Asset Related Charges - Net HTML 111K (DowDuPont Cost Synergy Program) (Details) 15: R68 Restructuring and Asset Related Charges - Net HTML 47K Restructuring and Asset Related Charges - Net (Asset Related Charges) (Details) 62: R69 Summary of Sundry Income (Expense) - Net (Details) HTML 86K 42: R70 Earnings Per Share (Details) HTML 113K 26: R71 Inventories (Schedule of Inventories) (Details) HTML 50K 73: R72 Nonconsolidated Affiliates (Details) HTML 52K 115: R73 GOODWILL AND OTHER INTANGIBLE ASSETS - Summary of HTML 53K Goodwill (Details) 43: R74 GOODWILL AND OTHER INTANGIBLE ASSETS - Summary of HTML 62K Other Intangible Assets (Details) 27: R75 GOODWILL AND OTHER INTANGIBLE ASSETS - Summary of HTML 42K Amortization Expense (Details) 74: R76 GOODWILL AND OTHER INTANGIBLE ASSETS - Summary of HTML 48K Future Amortization Expense (Details) 116: R77 TRANSFERS OF FINANCIAL ASSETS - Cash Proceeds HTML 35K (Details) 40: R78 NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT HTML 48K FACILITIES Notes Payable (Details) 31: R79 NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT HTML 187K FACILITIES Long-Term Debt (Details) 41: R80 NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT HTML 75K FACILITIES Committed and Available Credit Facilities (Details) 25: R81 NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT HTML 37K FACILITIES Debt Covenant and Default Provisions (Details) 72: R82 Commitments and Contingent Liabilities HTML 57K (Environmental Matters) (Narrative) (Details) 114: R83 Commitments and Contingent Liabilities HTML 42K (Asbestos-Related Matters of Union Carbide Corporation) (Table and Narrative) (Details) 44: R84 Commitments and Contingent Liabilites (Dow HTML 73K Silicones Chapter 11 Related Matters) (Details) (Details) 28: R85 COMMITMENTS AND CONTINGENT LIABILITIES HTML 49K Indemnifications with Corning (Details) 75: R86 Commitments and Contingent Liabilities (Nova HTML 53K Patent Infringement Matter) (Details) 117: R87 Commitments and Contingent Liabilities Nova HTML 56K Ethylene Asset Matter (Details) 39: R88 Commitments and Contingent Liabilities HTML 57K (Guarantees) (Table and Narrative) (Details) 29: R89 Leases (Details) HTML 161K 20: R90 STOCKHOLDERS' EQUITY STOCKHOLDERS' EQUITY - Common HTML 60K Stock (Details) 61: R91 STOCKHOLDERS' EQUITY STOCKHOLDERS' EQUITY - HTML 39K Retained Earnings (Details) 110: R92 STOCKHOLDERS' EQUITY STOCKHOLDERS' EQUITY - HTML 40K Treasury Stock (Details) 95: R93 STOCKHOLDERS' EQUITY STOCKHOLDERS' EQUITY - HTML 107K Accumulated Other Comprehensive Loss (Details) 17: R94 NONCONTROLLING INTERESTS Noncontrolling Interests HTML 78K (Details) 58: R95 Pension Plans and Other Postretirement Benefits HTML 84K (Details) 107: R96 Stock-Based Compensation (Stock Incentive Plan) HTML 62K (Details) 92: R97 FINANCIAL INSTRUMENTS Fair Value of Financial HTML 142K Instruments (Details) 16: R98 FINANCIAL INSTRUMENTS Derivatives (Details) HTML 209K 63: R99 Fair Value Measurements (Summary of Recurring HTML 108K Measured Fair Values) (Details) 82: R100 Fair Value Measurements Fair Value Measurements HTML 99K (Summary of Nonrecurring Measured Fair Values) (Details) 96: R101 Variable Interest Entities (Schedule of HTML 74K Consolidated Variable Interest Entities, Carrying Amounts of Assets and Liabilities) (Details) 55: R102 Variable Interest Entities (Nonconsolidated HTML 45K Variable Interest Entity) (Details) 14: R103 Relatd Party Transactions (Details) HTML 64K 83: R104 SEGMENTS AND GEOGRAPHIC REGIONS Segment HTML 64K Information (Details) 97: R105 SEGMENTS AND GEOGRAPHIC REGIONS EBIT HTML 57K Reconciliation (Details) 57: R106 SEGMENTS AND GEOGRAPHIC REGIONS Significant Items HTML 89K (Details) 30: XML IDEA XML File -- Filing Summary XML 231K 56: XML XBRL Instance -- dowinc-q3x9302019_htm XML 6.27M 68: EXCEL IDEA Workbook of Financial Reports XLSX 165K 8: EX-101.CAL XBRL Calculations -- dow-20190930_cal XML 195K 9: EX-101.DEF XBRL Definitions -- dow-20190930_def XML 1.84M 10: EX-101.LAB XBRL Labels -- dow-20190930_lab XML 2.73M 11: EX-101.PRE XBRL Presentations -- dow-20190930_pre XML 2.17M 7: EX-101.SCH XBRL Schema -- dow-20190930 XSD 286K 81: JSON XBRL Instance as JSON Data -- MetaLinks 558± 862K 52: ZIP XBRL Zipped Folder -- 0001751788-19-000031-xbrl Zip 554K
Exhibit |
Dow Inc. and Subsidiaries The Dow Chemical Company and Subsidiaries | EXHIBIT 31.2 |
1. | I have reviewed this Quarterly Report on Form 10-Q of Dow Inc. and The Dow Chemical Company; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrants as of, and for, the periods presented in this report; |
4. | The registrants' other certifying officer and I are responsible for establishing and maintaining
disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrants and have: |
a) | designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrants, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b) | designed
such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c) | evaluated the effectiveness of the registrants' disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d) | disclosed
in this report any change in the registrants' internal control over financial reporting that occurred during the registrants' most recent fiscal quarter (the registrants' fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants' internal control over financial reporting; and |
5. | The registrants' other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants' auditors and the audit committee of registrants' board of directors (or persons performing the equivalent function): |
a) | all
significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants' ability to record, process, summarize and report financial information; and |
b) | any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants' internal control over financial reporting. |
President and Chief Financial Officer |
This ‘10-Q’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 10/25/19 | |||
For Period end: | 9/30/19 | 13F-HR | ||
List all Filings |